PRESS RELEASE published on 06/18/2026 at 18:30, 3 months 12 days ago Inside Information / Other news releases Theraclion announces changes in its Board of Directors with Mr. Yann Duchesne stepping down and new appointments made. New Interim Chairman appointed. Details on the company's MedTech advancements Board Of Directors MedTech Theraclion SONOVEIN HIFU
PRESS RELEASE published on 06/18/2026 at 18:30, 3 months 12 days ago Informations privilégiées / Autres communiqués THERACLION annonce l'évolution de son conseil d'administration avec le départ de M. Yann Duchesne et la nomination d'un nouveau CA et d'un président par intérim Conseil D'administration Theraclion SONOVEIN Yann Duchesne Claude Lenoir
BRIEF published on 12/09/2025 at 18:35, 9 months 22 days ago Theraclion Submits Sonovein to FDA After Year of Key Achievements FDA Submission Clinical Evidence SONOVEIN Regulatory Achievements Varicose Vein Treatment
BRIEF published on 12/09/2025 at 18:35, 9 months 22 days ago Theraclion submits Sonovein to the FDA after significant progress FDA Theraclion SONOVEIN Varicose Veins HIFU
BRIEF published on 12/09/2025 at 18:35, 9 months 22 days ago Theraclion soumet Sonovein à la FDA après d'importants progrès FDA Theraclion SONOVEIN Varices HIFU
BRIEF published on 12/09/2025 at 18:35, 9 months 22 days ago Theraclion soumet le Sonovein à la FDA après une année de succès clés Soumission À La FDA SONOVEIN Réalisations Réglementaires Traitement Des Varices Preuves Cliniques
PRESS RELEASE published on 12/09/2025 at 18:30, 9 months 22 days ago Informations privilégiées / Autres communiqués Theraclion annonce la soumission de Sonovein à la FDA après une année de progrès réglementaires et cliniques, avec des résultats encourageants et des avancées significatives en Europe et en Chine FDA Theraclion SONOVEIN Varices HIFU
PRESS RELEASE published on 12/09/2025 at 18:30, 9 months 22 days ago Inside Information / Other news releases Theraclion announces FDA submission of Sonovein following a year of regulatory and clinical achievements. Key milestones in Europe and China also reached Clinical Milestones FDA Submission Theraclion SONOVEIN Regulatory Achievements
BRIEF published on 10/29/2025 at 18:35, 11 months 2 days ago Theraclion annonce ses résultats financiers et ses progrès stratégiques pour le premier semestre 2025. Résultats Financiers Croissance Des Revenus Expansion Du Marché Étude Américaine Progression De La Certification
BRIEF published on 10/29/2025 at 18:35, 11 months 2 days ago Theraclion Announces 2025 Half-Year Financial Results and Strategic Progress Financial Results Revenue Growth Market Expansion U.S. Study Certification Progress
Published on 10/01/2026 at 01:21, 4 hours 13 minutes ago Revival Gold Announces Filing of Final Base Shelf Prospectus
Published on 10/01/2026 at 01:00, 4 hours 34 minutes ago Algo Grande Copper Secures Five-Year Surface Access Agreement With Ejido Palos Chinos at the Adelita Project
Published on 09/30/2026 at 23:30, 6 hours 4 minutes ago Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 8 hours 59 minutes ago Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 09/30/2026 at 15:50, 13 hours 44 minutes ago Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 10/01/2026 at 05:05, 29 minutes ago Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth
Published on 09/30/2026 at 23:23, 6 hours 11 minutes ago LM PAY S.A. publishes audited FY 2025 results: EBIT reaches PLN 12.4 million and exceeds preliminary result and guidance
Published on 09/30/2026 at 22:34, 7 hours ago The Change of Date of the Annual Report 2025 Publication
Published on 09/30/2026 at 22:05, 7 hours 29 minutes ago ADS-TEC Energy Reports First Half 2026 Results; Advances Gigawatt-Scale SKM Storage Project and Strengthens its Position to Scale Own & Operate Model
Published on 09/30/2026 at 22:05, 7 hours 29 minutes ago Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Published on 09/30/2026 at 18:44, 10 hours 49 minutes ago Broadcast of the 5th edition of “On the way up”
Published on 09/30/2026 at 18:44, 10 hours 49 minutes ago Diffusion de la 5e édition de “On the way up”
Published on 09/30/2026 at 18:18, 11 hours 16 minutes ago Nombre total de droits de vote et d'actions composant le capital social
Published on 09/30/2026 at 18:15, 11 hours 19 minutes ago The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026
Published on 09/30/2026 at 18:15, 11 hours 19 minutes ago L’État belge et le groupe ENGIE ont convenu de reporter au 4 novembre 2026 la date cible pour la conclusion des Heads of Terms
